Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 16, 2021

Rhea-AI Summary

Eton Pharmaceuticals, Inc (Nasdaq: ETON) will announce its fourth quarter and full year 2020 financial results on March 16, 2021, at 4:30 p.m. ET. Management will host a conference call and audio webcast to discuss these outcomes and provide a business update. Interested parties can access the live webcast on Eton's investor section of its website. Eton focuses on developing innovative treatments for rare pediatric diseases and currently has three FDA-approved products and six additional products submitted for FDA review.

Positive

• Eton has three FDA-approved products, enhancing its revenue potential.
• Six additional products are submitted to the FDA, indicating pipeline growth.

Negative

• None.

DEER PARK, Ill., March 04, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced that it will report fourth quarter and full year 2020 financial and operating results on Tuesday, March 16, 2021. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 4:30 p.m. ET (3:30 p.m. CT). 

The live webcast can be accessed on the investors section of Eton’s website at https://ir.etonpharma.com/. The conference call can be accessed by dialing 1-866-795-8473 (domestic) or 1-470-495-9161 (international) and refer to conference ID 1891934. An archived webcast will be available on Eton’s website approximately two hours after the completion of the event and for 30 days thereafter.

About Eton Pharmaceuticals
Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases. The company currently owns or receives royalties from three FDA-approved products, including ALKINDI^® SPRINKLE, Biorphen^®, and Alaway Preservative Free^®, and has six additional products that have been submitted to the FDA.

Investor Contact:
David Krempa
dkrempa@etonpharma.com
612-387-3740

FAQ

When will Eton Pharmaceuticals report its 2020 financial results?

Eton Pharmaceuticals will report its financial results on March 16, 2021.

What time is Eton's conference call to discuss its financial results?

The conference call will be held at 4:30 p.m. ET.

How can I access Eton's financial results webcast?

You can access the webcast on the investor section of Eton's website.

What FDA-approved products does Eton Pharmaceuticals currently have?

Eton has three FDA-approved products: ALKINDI® SPRINKLE, Biorphen®, and Alaway Preservative Free®.

How many additional products has Eton submitted to the FDA?

Eton has submitted six additional products to the FDA.